2019-Novel Coronavirus, Influenza A and B virus nucleic acid test kit (Fluorescent Probe-based real-time PCR assay) The 2019-Novel Coronavirus (2019-nCoV)belong to the β genes.People infected with the virus can cause a variety of respiratory symptoms. In severe cases, it can lead to pneumonia, severe acute respiratory syndrome, renal failure, and even death. Influenza virus is a type of pathogen that can cause acute respiratory infections in humans. It is highly infectious, spreads quickly, has a high morbidity rate and is accompanied by a certain mortality. Influenza A virus and influenza B virus are the two most common influenza viruses, which have caused large-scale epidemics on a global scale many times. Jiangsu· Taizhou Jiangsu Mole Bioscience Co.,Ltd. Stock code ： 839185 Add: 6-7th Floor, G116 Building, No.805, Jiankang Add: 4-5th Floor, Building No.5, Health Valley, No.1500 Wenyi Avenue, Medical New&Hi-tech District, Taizhou, xi Road, Yuhang District, Hangzhou, Jiangsu Province, China Tel： 0523-86080606 Zhejiang province, China Tel： 0571-872

Detection significance 1. In the period of COVID-19 pandemic, it can help doctors distinguish between the novel coronavirus infection and influenza virus infection, and make a targeted treatment plan; 2. Early diagnosis and early isolation can be achieved for the infection of the three pathogens, in order to block the transmission of pathogens, and reduce the risk of epidemic transmission. Test principle Using multiple fluorescent PCR technology to detect the 2019-Novel coronavirus (ORF1ab gene), influenza A virus (M1 gene) and influenza B virus (NS1 gene) in human respiratory samples at the same...